Balyasny Asset Management
PASG icon

Balyasny Asset Management’s Passage Bio PASG Stock Holding History

Balyasny Asset Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$522K Buy
+107,025
New +$670K ﹤0.01% 2496

Other funds holding PASG

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Balyasny Asset Management's PASG Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in Passage Bio (PASG) in Q2 2026: 107,025 shares worth $522K. The stake represents ﹤0.01% of the portfolio and ranks #2496 among its holdings.

28 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Balyasny Asset Management held 107,025 shares of Passage Bio worth $522K as of Q2 2026.
  • Passage Bio was a new Balyasny Asset Management position in Q2 2026.
  • Passage Bio made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2496 holding.
  • 28 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.